Levitra 10 mg orodispersible tablets
Authorisation EU/1/03/248/013-15 · Bayer Schering Pharma AG
- Licence holder
- Bayer Schering Pharma AG (all products →)
- Active substance
- VARDENAFIL HYDROCHLORIDE TRIHYDRATE
- Dosage form
- Orodispersible tablet
- Route of administration
- Oral use
- ATC codes
- G04BE, G04BE09
- First authorised
- 01/09/2010
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- New active substance (Article 8(3) of Directive No 2001/83/EC)
VARDENAFIL HYDROCHLORIDE TRIHYDRATE: supply and approvals
5 authorised products on the HPRA list contain VARDENAFIL HYDROCHLORIDE TRIHYDRATE. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 248. It has been authorised for 16 years (since 1 September 2010). The HPRA list does not say whether it is on sale.
Other medicines with VARDENAFIL HYDROCHLORIDE TRIHYDRATE in Ireland
3 other products on the HPRA list contain VARDENAFIL HYDROCHLORIDE TRIHYDRATE, from 1 licence holder; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Vardenafil Krka 10 mg film-coated tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Not marketed |
| Vardenafil Krka 20 mg film-coated tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Not marketed |
| Vardenafil Krka 5mg film-coated tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Not marketed |
Other substances in ATC group G04BE
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 7 other active substances share the group G04BE with this product:
Sildenafil (32) · Tadalafil (23) · Alprostadil (4) · Sildenafil citrate (3) · Avanafil (3) · Vardenafil (1) · Sildenafil citrate for parenteral use (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Bayer Schering Pharma AG holds 8 products on the HPRA list, with 2 different active substances; 0 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.